Screening for metabolic syndrome in patients newly diagnosed with hypothyroidism to identify the compounding effect on cardiovascular disease risk

Arslan Mohammed; Suchitra M. Manohar; Kusuma Kumari M.; Alok Sachan

doi:10.18203/2320-6012.ijrms20260627

Authors

Arslan Mohammed Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
Suchitra M. Manohar Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
Kusuma Kumari M. Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
Alok Sachan Department of Endocrinology and Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260627

Keywords:

Newly diagnosed hypothyroidism, Components of metabolic syndrome, Insulin resistance, Anthropometric indices, Screening, Cardiovascular disease risk

Abstract

Background: Lowered thyroid hormones and elevated thyroid stimulating hormone (TSH) levels of hypothyroid state are found to be associated with metabolic changes encompassing components of metabolic syndrome (MetS). Both hypothyroidism and MetS are individually associated with risk of cardiovascular disease (CVD). The presence of MetS can have a compounding effect on the CVD risk in hypothyroidism.

Methods: A case-control cross sectional study was done in 30 newly diagnosed hypothyroid cases and 30 healthy controls. Waist circumference (WC), height, weight and blood pressure (BP) were recorded; fasting venous blood sample was collected for thyroid function tests, glucose, lipids and insulin. Insulin resistance as homeostasis model assessment for insulin resistance (HOMA-IR) and body mass index (BMI) was calculated. Comparison of means and correlation analysis was done using SPSS version 22.

Results: Higher BMI (p=0.001), WC (p<0.001), BP (systolic p=0.039; diastolic p<0.001), total cholesterol (TC) (p=0.001), triglycerides (TGL) (p<0.001), very low-density lipoproteins (p<0.001) and fasting plasma glucose (FPG) levels (p<0.001) were observed in hypothyroid subjects. MetS was found in 11 of the 22 females and three of the eight male subjects with hypothyroidism. Presence of individual components of MetS in hypothyroidism was WC (90%), TGLs (83.3%) and high density lipoprotein (HDL) (73.3%). All female subjects in both groups had higher WC. Among female controls, two had MetS. Hypothyroidism was found to associated with components of MetS.

Conclusions: Hypothyroidism associated metabolic changes can lead to the development of MetS. Targeted therapeutic interventions and life style modifications can attenuate compounding effect on of MetS on CVD risk in hypothyroidism.

Metrics

Metrics Loading ...

References

Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647-52. DOI: https://doi.org/10.4103/2230-8210.113755

Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84. DOI: https://doi.org/10.2174/1874192401105010076

Tehrani FR, Tohidi M, Dovom MR, Azizi F. A population based study on the association of thyroid status with components of the metabolic syndrome. J Diabetes Metab. 2011;2(8):156-62. DOI: https://doi.org/10.4172/2155-6156.1000156

Muthu Reka S, Vijayanchali SS. Prevalence of Metabolic Syndrome in India. IJISRT. 2024;9(6):1046-56. DOI: https://doi.org/10.38124/ijisrt/IJISRT24JUN313

Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, et al. The relationship between serum thyrotropin and components of metabolic syndrome. Endocrine J. 2011;58(1):23-30. DOI: https://doi.org/10.1507/endocrj.K10E-272

Wasalwar GV, Wasnik DS. Prevalence of Metabolic Syndrome in Hypothyroidism Patients. Int J Cur Res Rev. 2020;12(17):2-6. DOI: https://doi.org/10.31782/IJCRR.2020.12175

Erdogan M, Canataroglu A, Ganidagli S, Kulaksizoglu M. Metabolic syndrome prevalence in subclinical and overt hypothyroid patients and relation among metabolic syndrome parameters. J Endocrinol Investig. 2011;34(7):488-92.

El-Hay GAESA, Argoon SA, Mousa NMMA. Evaluation of the frequency and patterns of thyroid dysfunction in patients with metabolic syndrome. Egypt J Intern Med. 2021;33(1):24. DOI: https://doi.org/10.1186/s43162-021-00054-z

Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000;160(11):1573-75. DOI: https://doi.org/10.1001/archinte.160.11.1573

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. DOI: https://doi.org/10.1093/clinchem/18.6.499

World Health Organization. Waist circumference and waist-hip ratio report of a WHO expert consultation, Geneva. 2011. Available at: https://www.who.int/publications/i/item/9789241501491. Accessed on 15 December 2025.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. DOI: https://doi.org/10.1007/BF00280883

Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, ad treatment of high blood cholesterol in adults, Adult Treatment Panel III final report. Circulation. 2002;106(25):3143-21. DOI: https://doi.org/10.1161/circ.106.25.3143

Ramya Reddy R, Swarnalatha N. Correlation of anthropometric indices with lipid profile in adult females. National J Physiol Pharmacy Pharmacol. 2018;8(4):512-6.

Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bansali A, Dhandania VK, et al. Prevalence of dyslipidemia in urban and rural India. The ICMR-INDIAB study plosone. 2014;9(5):e96808. DOI: https://doi.org/10.1371/journal.pone.0096808

Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab. 2016;20(4):554-7. DOI: https://doi.org/10.4103/2230-8210.183454

HuxleyR, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk-A review of the literature. Eur J Clin Nutr. 2010;64:16 22. DOI: https://doi.org/10.1038/ejcn.2009.68

Reddy KS, Reddy KK, Sudha G. Overall and abdominal adiposity on blood pressure: consistency and evaluation of their association in an adult Indian population. J Life Sci. 2010;2:117-25. DOI: https://doi.org/10.1080/09751270.2010.11885161

Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010;8:1559-65. DOI: https://doi.org/10.1586/erc.10.141

Stanislovas S. Jankauskas, Marco B. Morelli, Jessica Gambardella, Angela Lombardi, Gaetano Santulli. Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension. J Clin Hypertens. 2021;23:373-81. DOI: https://doi.org/10.1111/jch.14152

Ijaz A. Association of Hypothyroidism with Metabolic Syndrome. J Islamic Intern Medic Col. 2019;13:172-3.

Kota SK, Meher LK, Krishna S, Modi K. Hypothyroidism in metabolic syndrome. Indian J Endocrinol Metabolism. 2012;16(2):332-3. DOI: https://doi.org/10.4103/2230-8210.104079

Jang J, Kim Y, Shin J, Lee SA, Choi Y, Park EC. Association between thyroid hormones and the components of metabolic syndrome. BMC Endocr Disord. 2018;18(1):29. DOI: https://doi.org/10.1186/s12902-018-0256-0

Eom YS, Wilson JR, Bernet VJ. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes Metab J. 2022;46(2):239-56. DOI: https://doi.org/10.4093/dmj.2022.0013